🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

RecruitingNAAges 18 Years - 100 YearsMaleNorthwestern University
NCT07632742 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Undergoing HoLEP for the treatment of bothersome lower urinary tract symptoms * Internet access and a device to complete postoperative questionnaires (smartphone, tablet, laptop or desktop computer) Exclusion Criteria: * Patients who lack decisional capacity * Patients unable to read/speak English * Patients who are on a blood thinner (anticoagulation medication) * Patients who do not have internet access to complete postoperative surveys
💊

What it tests

  • Magneto 150 holmium laser
  • Moses 2.0 holmium laser
📍

Where

1 site
Northwestern University
Chicago, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy